ARHGAP6 and nasopharyngeal carcinoma: For the female group, the combined analysis revealed that rs5933886 in ARHGAP6 was associated with NPC risk (P = 2.05 × 10−4), and the association was validated in the Taiwan dataset (P = 1.64 × 10−2; Fig. 4c and Additional file 1: Table S6).